DOJ Reaches $45 Million False Claims Act Settlement with Specialty Wound Care Providers in Record Time

On November 21, 2025, the DOJ announced that Dr. Ameet Vohra and his company, Vohra Wound Physicians Management, one of the nation's largest providers of specialty wound care for patients in nursing homes and skilled nursing facilities, have agreed to pay $45 million to resolve allegations that they submitted false and improper claims to Medicare. […]

Read More
$37 Million False Claims Act Settlement against Semler Scientific and Bard is Latest in DOJ Crackdown on Alleged Peripheral Vascular Fraud

Medical Device Company Semler Scientific and its former distributor Bard Peripheral Vascular Inc. recently reached a $37 million settlement with DOJ to resolve allegations raised by two whistleblowers that they violated the False Claims Act (FCA). Of the almost $37 million settlement, Semler will pay $29.7 million and Bard will pay $7.2 million. The qui […]

Read More
New Economic Study: Healthcare Whistleblowers Save Government 10x Settlement Amounts

A recent study by Boston University professor Jetson Leder-Luis, entitled Can Whistleblowers Root Out Public Expenditure Fraud? Evidence from Medicare, found that deterrence from $1.9 billion in False Claims Act settlement payments generated almost $19 billion in Medicare cost savings – a 10:1 deterrent effect. Professor Leder-Luis concludes that whistleblower-initiated False Claims Act cases are […]

Read More
Double Duty, Double Trouble: DC Assistant Principal Faces False Claims Act Penalty for Working Two Jobs

Teachers should make more money. Even principals should make more money. But they probably shouldn’t do it by secretly holding two jobs with overlapping hours at the same time. The Washington, DC Attorney General’s office recently announced a settlement under its District False Claims Act (the DC equivalent of a state False Claims Act) against […]

Read More
Recent Price-Fixing Conviction Is a Roadmap for Antitrust Whistleblowers

A recent price-fixing guilty plea provides a roadmap for antitrust whistleblowers looking to report wrongdoing and receive a reward. Last month, DOJ announced the guilty plea of Dennis Dopico, who conspired to fix seafood prices in Florida. DOJ alleged that Dopico conspired for years with other wholesalers to fix the prices of stone crab claws […]

Read More
Uptick in FCA Settlements Underscores that Cybersecurity Compliance is a DOJ Priority

The DOJ has settled the sixth cybersecurity False Claims Act case in just eight months, marking fourteen settlements in less than four years since the DOJ launched its Civil Cyber-Fraud Initiative (CCFI). These settlements and the upcoming (and long-awaited) implementation of the CMMC program cement cybersecurity compliance as a DOJ enforcement priority and underscore the […]

Read More
Appeals Court Signals IRS Must Properly Justify Lower Awards

In an opinion issued September 24, 2025, the D.C. Circuit held in favor of a tax whistleblower in a decision that could mark a turning point for judicial review of the IRS tax whistleblower program. Although there has been no shortage of litigation around the program, wins for whistleblowers are extremely rare, especially on anything […]

Read More
Recent Suit Highlights Medical Loss Ratio Fraud in Managed Care Programs

A lawsuit filed last week by the Department of Justice brings attention to a seldom litigated allegation of fraud against the government: manipulation of a health plan’s Medical Loss Ratio (“MLR”). In general, an MLR is what percentage of premiums a health plan is legally required to spend on patient care, as opposed to money […]

Read More
Seventh Circuit FCA Opinion Upholds $183 Million False Claims Act Award

In a recent decision out of the Seventh Circuit, the court upheld a jury verdict that resulted in a $183 million False Claims Act award against Eli Lilly (“Lilly”), the pharmaceutical company. The case, United States ex. rel Streck v. Eli Lilly, was brought by a whistleblower named Ronald Streck, who litigated the case after […]

Read More
New HHS-OIG Report Highlights Fraud Risks in Wound Care and Skin Substitutes

Medicare, the government-funded insurance program for the elderly and disabled, covers certain wound care products known as skin substitutes, basically artificial skin that’s used to replace damaged or missing skin. A new report by the Office of Inspector General draws attention to skyrocketing costs and potential fraud in the industry. In just two years, Medicare […]

Read More
1 2 3 9